These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2853605)

  • 21. The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
    Pinto A; Iwasa K; Newland C; Newsom-Davis J; Lang B
    Muscle Nerve; 2002 May; 25(5):715-724. PubMed ID: 11994966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Springer Semin Immunopathol; 1985; 8(1-2):129-40. PubMed ID: 2988146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line.
    Peers C; Lang B; Newsom-Davis J; Wray DW
    J Physiol; 1990 Feb; 421():293-308. PubMed ID: 2161458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels.
    Spillane J; Ermolyuk Y; Cano-Jaimez M; Lang B; Vincent A; Volynski KE; Kullmann DM
    Neurology; 2015 Feb; 84(6):575-9. PubMed ID: 25589670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leads.
    Meriney SD; Tarr TB; Ojala KS; Wu M; Li Y; Lacomis D; Garcia-Ocaña A; Liang M; Valdomir G; Wipf P
    Ann N Y Acad Sci; 2018 Jan; 1412(1):73-81. PubMed ID: 29125190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lambert-Eaton myasthenic syndrome.
    Mareska M; Gutmann L
    Semin Neurol; 2004 Jun; 24(2):149-53. PubMed ID: 15257511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory axoaxonal and neuromuscular synapses in the crayfish opener muscle: membrane definition and ultrastructure.
    Govind CK; Atwood HL; Pearce J
    J Comp Neurol; 1995 Jan; 351(3):476-88. PubMed ID: 7706554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromuscular Active Zone Structure and Function in Healthy and Lambert-Eaton Myasthenic Syndrome States.
    Ginebaugh SP; Badawi Y; Tarr TB; Meriney SD
    Biomolecules; 2022 May; 12(6):. PubMed ID: 35740866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
    Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
    Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse.
    Lang B; Newsom-Davis J; Peers C; Prior C; Wray DW
    J Physiol; 1987 Sep; 390():257-70. PubMed ID: 2450991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies to calcium channels in type 1 diabetes mediate autonomic dysfunction by different mechanisms in colon and bladder and are neutralized by antiidiotypic antibodies.
    Wan EC; Gordon TP; Jackson MW
    J Autoimmun; 2008 Aug; 31(1):66-72. PubMed ID: 18472396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricle.
    Lang B; Newsom-Davis J; Wray DW
    Proc R Soc Lond B Biol Sci; 1988 Oct; 235(1278):103-10. PubMed ID: 2907138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction.
    Pellkofer HL; Voltz R; Kuempfel T
    Muscle Nerve; 2009 Aug; 40(2):305-8. PubMed ID: 19609921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.
    Kim YI
    Muscle Nerve; 1985 Feb; 8(2):162-72. PubMed ID: 2997605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of synaptosomal calcium channel function by Lambert-Eaton myasthenic immunoglobulin is serum-dependent.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):317-23. PubMed ID: 1363288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-Eaton myasthenic syndrome.
    Houzen H; Hattori Y; Kanno M; Kikuchi S; Tashiro K; Motomura M; Nakao Y; Nakamura T
    Ann Neurol; 1998 May; 43(5):677-80. PubMed ID: 9585366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repetitive nerve stimulation studies in the Lambert-Eaton myasthenic syndrome.
    Tim RW; Sanders DB
    Muscle Nerve; 1994 Sep; 17(9):995-1001. PubMed ID: 8065402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient subacute cerebellar ataxia in a patient with Lambert-Eaton myasthenic syndrome after intracranial aneurysm surgery.
    Nakamura M; Yabe I; Sato K; Nakano F; Yaguchi H; Tsuji S; Shiraishi H; Yoneda M; Tanaka K; Motomura M; Sasaki H
    Clin Neurol Neurosurg; 2008 May; 110(5):480-3. PubMed ID: 18295972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
    Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
    J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.